Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Fisher B, Anderson S, Bryant J, et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 2002;347(16):1233–1241
Veronesi U, Cascinelli N, Mariani L, et al. Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med 2002;347(16):1227–1232
Hahn CA, Marks LB, Chen DY, et al. Breast conservation rates-barriers between tertiary care and community practice. Int J Radiat Oncol Biol Phys 2003;55(5):1196–1199
Schnitt SJ, Hayman J, Gelman R, et al. A prospective study of conservative surgery alone in the treatment of selected patients with stage I breast cancer. Cancer 1996;77(6):1094–1100
Renton SC, Gazet JC, Ford HT, et al. The importance of the resection margin in conservative surgery for breast cancer. Eur J Surg Oncol 1996;22(1):17–22
Fisher ER, Anderson S, Tan-Chiu E, et al. Fifteen-year prognostic discriminants for invasive breast carcinoma. Cancer 2001;91(S8):1679–1687
Veronesi U, Marubini E, Mariani L, et al. Radiotherapy after breast-conserving surgery in small breast carcinoma: long-term results of a randomized trial. Ann Oncol 2001;12(7):997–1003
Liljegren G, Holmberg L, Bergh J, et al. 10-Year results after sector resection with or without postoperative radiotherapy for stage I breast cancer: a randomized trial. J Clin Oncol 1999;17(8):2326–2333
Clark RM, Whelan T, Levine M, et al. Randomized clinical trial of breast irradiation following lumpectomy and axillary dissection for node-negative breast cancer: an update. Ontario Clinical Oncology Group. J Natl Cancer Inst 1996;88(22):1659–1664
Holli K, Saaristo R, Isola J, et al. Lumpectomy with or without postoperative radiotherapy for breast cancer with favourable prognostic features: results of a randomized study. Br J Cancer 2001;84(2):164–169
Bartelink H, Horiot JC, Poortmans PM, et al. Recurrence rates after treatment of breast cancer with standard radiotherapy with or without additional radiation. N Engl J Med 2001;345(19):1378–1387
Romestaing P, Lehingue Y, Carrie C, et al. Role of a 10-Gy boost in the conservative treatment of early breast cancer: results of a randomized clinical trial in Lyon, France. J Clin Oncol 1997;15(3):963–968
Dalberg K, Johansson H, Johansson U, et al. A randomized trial of long term adjuvant tamoxifen plus postoperative radiation therapy versus radiation therapy alone for patients with early stage breast carcinoma treated with breast-conserving surgery. Stockholm Breast Cancer Study Group. Cancer 1998;82(11):2204–2211
Cooke AL, Perera F, Fisher B, et al. Tamoxifen with and without radiation after partial mastectomy in patients with involved nodes. Int J Radiat Oncol Biol Phys 1995;31(4):777–781
Fisher B, Redmond C, Legault-Poisson S, et al. Postoperative chemotherapy and tamoxifen compared with tamoxifen alone in the treatment of positive-node breast cancer patients aged 50 years and older with tumors responsive to tamoxifen: results from the National Surgical Adjuvant Breast and Bowel Project B-16. J Clin Oncol 1990;8(6):1005–1018
Fowble B, Fein DA, Hanlon AL, et al. The impact of tamoxifen on breast recurrence, cosmesis, complications, and survival in estrogen receptor-positive early-stage breast cancer. Int J Radiat Oncol Biol Phys 1996;35(4):669–677
Fisher B, Bryant J, Dignam JJ, et al. Tamoxifen, radiation therapy, or both for prevention of ipsilateral breast tumor recurrence after lumpectomy in women with invasive breast cancers of one centimeter or less. J Clin Oncol 2002;20(20):4141–4149
Whelan T, MacKenzie R, Julian J, et al. Randomized trial of breast irradiation schedules after lumpectomy for women with lymph node-negative breast cancer. J Natl Cancer Inst 2002;94(15):1143–1150
Kuske RR, Martin B, Hanson W, Arthur DW, Rabinovitch R, White J et al. Quality assurance and reproducibility on RTOG 95-17: A phase II trial of brachytherapy alone for select breast cancers. Radiology 2001, 221: Abstract 238
Vicini FA, Kestin L, Chen P, et al. Limited-field radiation therapy in the management of early-stage breast cancer. J Natl Cancer Inst 2003;95(16):1205–1210
Kuske RR. Breast brachytherapy. Hematol Oncol Clin North Am 1999;13(3):543–vii
Vicini FA, Jaffray DA, Horwitz EM, et al. Implementation of 3D-virtual brachytherapy in the management of breast cancer: a description of a new method of interstitial brachytherapy. Int J Radiat Oncol Biol Phys 1998;40(3):629–635
Arthur D, Koo D, Zwicker RD. Partial breast brachytherapy following lumpectomy: A low dose rate and high dose rate experience. Int J Radiat Oncol Biol Phys 2003;56(3):681–689
Keisch M, Vicini F, Kuske RR, et al. Initial clinical experience with the MammoSite breast brachytherapy applicator in women with early-stage breast cancer treated with breast-conserving therapy. Int J Radiat Oncol Biol Phys 2003;55(2):289–293
Edmundson GK, Vicini FA, Chen PY, et al. Dosimetric characteristics of the MammoSite RTS, a new breast brachytherapy applicator. Int J Radiat Oncol Biol Phys 2002;52(4):1132–1139
Streeter OE, Jr. Vicini FA, Keisch M, et al. MammoSite radiation therapy system. Breast 2003;12(6):491–496
Keisch M, Vicini F. In response to Drs. Kuerer, Pawlik, and Strom. Int J Radiat Oncol Biol Phys 2003;57(3):900–902
Ribeiro GG, Dunn G, Swindell R, et al. Conservation of the breast using two different radiotherapy techniques: interim report of a clinical trial. Clin Oncol (R Coll Radiol) 1990;2(1):27–34
Formenti SC, Rosenstein B, Skinner KA, et al. T1 stage breast cancer: adjuvant hypofractionated conformal radiation therapy to tumor bed in selected postmenopausal breast cancer patients—pilot feasibility study. Radiology 2002;222(1):171–178
Baglan KL, Sharpe MB, Jaffray D, et al. Accelerated partial breast irradiation using 3D conformal radiation therapy (3D-CRT). Int J Radiat Oncol Biol Phys 2003;55(2):302–311
Vicini FA, Remouchamps V, Wallace M, et al. Ongoing clinical experience utilizing 3D conformal external beam radiotherapy to deliver partial-breast irradiation in patients with early-stage breast cancer treated with breast-conserving therapy. Int J Radiat Oncol Biol Phys 2003;57(5):1247–1253
Dale RG. The application of the linear-quadratic dose-effect equation to fractionated and protracted radiotherapy. Br J Radiol 1985;58(690):515–528
Buchali A, Geismar D, Hinkelbein M, et al. Virtual simulation in patients with breast cancer. Radiother Oncol 2001;59(3):267–272
Butker EK, Helton DJ, Keller JW, et al. A totally integrated simulation technique for three-field breast treatment using a CT simulator. Med Phys 1996;23(10):1809–1814
Aref A, Thornton D, Youssef E, et al. Dosimetric improvements following 3D planning of tangential breast irradiation. Int J Radiat Oncol Biol Phys 2000;48(5):1569–1574
Delaney G, Beckham W, Veness M, et al. Three-dimensional dose distribution of tangential breast irradiation: results of a multicentre phantom dosimetry study. Radiother Oncol 2000;57(1):61–68
Pierce LJ, Butler JB, Martel MK, et al. Postmastectomy radiotherapy of the chest wall: dosimetric comparison of common techniques. Int J Radiat Oncol Biol Phys 2002;52(5):1220–1230
Krueger EA, Fraass BA, Pierce LJ. Clinical aspects of intensity-modulated radiotherapy in the treatment of breast cancer. Semin Radiat Oncol 2002;12(3):250–259
Kestin LL, Sharpe MB, Frazier RC, et al. Intensity modulation to improve dose uniformity with tangential breast radiotherapy: initial clinical experience. Int J Radiat Oncol Biol Phys 2000;48(5):1559–1568
Hong L, Hunt M, Chui C, et al. Intensity-modulated tangential beam irradiation of the intact breast. Int J Radiat Oncol Biol Phys 1999;44(5):1155–1164
Vicini FA, Sharpe M, Kestin L, et al. Optimizing breast cancer treatment efficacy with intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys 2002;54(5):1336–1344
Zackrisson B, Arevarn M, Karlsson M. Optimized MLC-beam arrangements for tangential breast irradiation. Radiother Oncol 2000;54(3):209–212
Li JG, Williams SS, Goffinet DR, et al. Breast-conserving radiation therapy using combined electron and intensity-modulated radiotherapy technique. Radiother Oncol 2000;56(1):65–71
Donovan EM, Johnson U, Shentall G, et al. Evaluation of compensation in breast radiotherapy: a planning study using multiple static fields. Int J Radiat Oncol Biol Phys 2000;46(3):671–679
Overgaard M, Hansen PS, Overgaard J, et al. Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish Breast Cancer Cooperative Group 82b Trial. N Engl J Med 1997;337(14):949–955
Overgaard M, Jensen MB, Overgaard J, et al. Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trial. Lancet 1999;353(9165):1641–1648
Ragaz J, Jackson SM, Le N, et al. Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer. N Engl J Med 1997;337(14):956–962
Cho BC, Hurkmans CW, Damen EM, et al. Intensity modulated versus non-intensity modulated radiotherapy in the treatment of the left breast and upper internal mammary lymph node chain: a comparative planning study. Radiother Oncol 2002;62(2):127–136
Remouchamps VM, Vicini FA, Sharpe MB, et al. Significant reductions in heart and lung doses using deep inspiration breath hold with active breathing control and intensity-modulated radiation therapy for patients treated with locoregional breast irradiation. Int J Radiat Oncol Biol Phys 2003;55(2):392–406
Hall EJ, Wuu CS. Radiation-induced second cancers: the impact of 3D-CRT and IMRT. Int J Radiat Oncol Biol Phys 2003;56(1):83–88
Forrest AP, Stewart HJ, Everington D, et al. Randomised controlled trial of conservation therapy for breast cancer: 6-year analysis of the Scottish trial. Scottish Cancer Trials Breast Group. Lancet 1996;348(9029):708–713
Wolmark N, Dignam J, Margolese R, Wickerham DL, Fisher B. The role of radiotherapy and tamoxifen in the management of node negative invasive breast cancer-1.0 cm treated with lumpectomy: Preliminary results of NSABP Protocol B-21. Proc Am Soc Clin Oncol 2000;19:70a
Fyles A, Manchul L, McCready DR, Trudeau M, Oliviotto I, Weir LM et al. Preliminary results of a randomized study of tamoxifen alone or tamoxifen and breast radiation in women over 50 years of age with T1/2 NO disease. Int J Radiat Oncol Biol Phys 2001;51(Suppl 3):106
Hughes KS, Schnaper D, Berry D, Cirrincione C, McCormick B, Shank B et al. Comparison of lumpectomy plus tamoxifen with and without radiotherapy (RT) in women 70 years of age or older who have clinical stage I, estrogen receptor positive (ER+) breast carcinoma. Proc Am Soc Clin Oncol 2001;20:24a
King TA, Bolton JS, Kuske RR, et al. Long-term results of wide-field brachytherapy as the sole method of radiation therapy after segmental mastectomy for T(is,1,2) breast cancer. Am J Surg 2000;180(4):299–304
Lo YC, Yasuda G, Fitzgerald TJ, et al. Intensity modulation for breast treatment using static multi-leaf collimators. Int J Radiat Oncol Biol Phys 2000;46(1):187–194
Hurkmans CW, Saarnak AE, Pieters BR, et al. An improved technique for breast cancer irradiation including the locoregional lymph nodes. Int J Radiat Oncol Biol Phys 2000;47(5):1421–1429
Evans PM, Donovan EM, Partridge M, et al. The delivery of intensity modulated radiotherapy to the breast using multiple static fields. Radiother Oncol 2000;57(1):79–89
Chui CS, Hong L, Hunt M, et al. A simplified intensity modulated radiation therapy technique for the breast. Med Phys 2002;29(4):522–529.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2006 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Vicini, F.A., Krauss, D., Arthur, D. (2006). Tailored Radiotherapy for Breast Cancer Stages I and II: Technical Aspects. In: Piccart, M.J., Hung, MC., Solin, L.J., Cardoso, F., Wood, W.C. (eds) Breast Cancer and Molecular Medicine. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-28266-2_12
Download citation
DOI: https://doi.org/10.1007/978-3-540-28266-2_12
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-28265-5
Online ISBN: 978-3-540-28266-2
eBook Packages: MedicineMedicine (R0)